EAISX | VGTSX | EAISX / VGTSX | |
Total Expense Ratio | 0.78 | 0.17 | 459% |
Annual Report Gross Expense Ratio | 0.88 | 0.17 | 518% |
Fund Existence | 16 years | 29 years | - |
Gain YTD | 25.512 | 26.104 | 98% |
Front Load | 5% | N/A | - |
Min. Initial Investment | 1000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 287M | 546B | 0% |
Annual Yield % from dividends | 2.65 | 2.68 | 99% |
Returns for 1 year | 15.65 | 18.03 | 87% |
Returns for 3 years | 58.99 | 62.39 | 95% |
Returns for 5 years | 40.15 | 44.84 | 90% |
Returns for 10 years | 66.29 | 69.52 | 95% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FINSX | 50.97 | 0.06 | +0.12% |
Fidelity Advisor New Insights I | |||
FIRCX | 10.04 | 0.01 | +0.10% |
Fidelity Advisor Intl Real Estate C | |||
NBHAX | 15.14 | 0.01 | +0.07% |
Neuberger Berman Equity Income A | |||
BIPSX | 29.24 | -0.05 | -0.17% |
ProFunds Biotechnology UltraSector Svc | |||
GEMCX | 24.24 | -0.05 | -0.21% |
Goldman Sachs Emerging Markets Eq C |